Analysis of common IL-6 promoter SNP variants and the AnTn tract in humans and primates and effects on plasma IL-6 levels following coronary artery bypass graft surgery

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1688, Issue 2, 2004, Pages 160-167

  Kelberman, Daniel ^a   Fife, Mark ^b   Rockman, Matthew V ^c   Brull, David J ^a   Woo, Patricia ^b   Humphries, Steve E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery bypass graft surgery; Coronary heart disease; Haplotype analysis; Interleukin 6; Promoter polymorphism

Indexed keywords

ADENINE; INTERLEUKIN 6; THYMINE;

ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CYTOKINE PRODUCTION; DNA FLANKING REGION; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIMATE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

PRIMATES;

EID: 1342264352     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.11.010     Document Type: Article

References (24)

1. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101:2000;1767-1772.
2. Biasucci L.M., Liuzzo G., Fantuzzi G., Caligiuri G., Rebuzzi A.G., Ginnetti F., Dinarello C.A., Maseri A. Increasing levels of interleukin (IL) -1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 99:1999;2079-2084.
3. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S.E., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102:1998;1369-1376.
4. Terry C.F., Loukaci V., Green F.R. Co-operative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275:2000;18138-18144.
5. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., Lowe G.D.O., Humphries S.E. Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler. Thromb. Vasc. Biol. 21:2001;1458-1463.
6. Tanabe O., Akira S., Kamiya T., Wong G.G., Hirano T., Kishimoto T. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J. Immunol. 141:1988;3875-3881.
7. Sablotzki A., Dehne M.G., Mann V., Gorlach G., Muhling J., Zickmann B., Hemplemann G. Plasma levels of selectins and interleukins in cardiovascular surgery using cardiopulmonary bypass. Thorac. Cardiovasc. Surg. 47:1999;26-31.
8. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 22:2001;2243-2252.
9. Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D., Ruidavets J.B., Cambien F., Tiret L. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study: Etude Cas-Temoin de L'infarctus du Myocarde. J. Mol. Med. 79:2001;300-305.
10. Basso F., Lowe G.D., Rumley A., McMahon A.D., Humphries S.E. Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS). Arterioscler. Thromb. Vasc. Biol. 22:2002;599-604.
11. Jenny N.S., Tracy R.P., Ogg M.S., Ahn-Luong L., Kuller L.H., Arnold A.M., Sharrett A.R., Humphries S.E. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22:2002;2066-2071.
12. Ferrari S.L., Ahn-Luong L., Garnero P., Humphries S.E., Greenspan S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J. Clin. Endocrinol. Metab. 88:2003;255-259.
13. Brull D.J., Sanders J., Rumley A., Lowe G.D., Humphries S.E., Montgomery H.E. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart. 87:2002;252-255.
14. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68:2001;978-989.
15. D.L. Swofford, PAUP. Phylogenetic analysis using parsimony (and other methods). Version 4.0b10. Sinauer Associates, Sunderland, Massechussetts. 2002.
16. Chen F.-C., Li W.-H. Genomic divergences between humans and other hominoids and the effective population size of the common ancestor of humans and chimpanzees. Am. J. Hum. Genet. 68:2001;444-456.
17. Ye S., Eriksson P., Hamsten A., Kurkinen M., Humphries S.E., Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human Stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 271:1996;13055-13060.
18. Song Q., Chao J., Chao L. DNA polymorphisms in the 5′-flanking region of the human tissue kallikrein gene. Hum. Genet. 99:1997;727-734.
19. Rockman M.V., Wray G.A. Abundant raw material for cis-regulatory evolution in humans. Mol. Biol. Evol. 19:2002;1991-2004.
20. Lew A., Rutter W.J., Kennedy G.C. Unusual DNA structure of the diabetes susceptibility locus IDDM2 and its effect on transcription by the insulin promoter factor Pur-1/MAZ. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12508-12512.
21. Lee M.K., Park A.J., Kim D.H. Tumor necrosis factor-α and interleukin-6 promoter gene polymorphisms are not associated with increased risk of endometriosis. Fertil. Steril. 77:2002;1304-1305.
22. Zhai R., Liu G., Yang C., Huang C., Wu C., Christiani D.C. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a southern Chinese population. Pharmacogenetics. 11:2001;699-701.
23. Vozarova B., Fernández-Real J.-M., Knowler W.C., Gallart L., Hanson R.L., Gruber J.D., Ricart W., Vendrell J., Richsrt C., Tataranni P.A., Wolford J.K. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in native Americans and Caucasians. Hum. Genet. 112:2003;409-413.
24. SeattleSNPs. NHLBI program for genomic applications, UW-FHCRC, Seattle, WA. (URL: http://pga.mbt.washington.edu ). February 2003.